These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 16985183

  • 1. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
    Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, Kojima M, Miura I, Mori N, Yoshino T, Nakamura S.
    Blood; 2007 Jan 15; 109(2):478-85. PubMed ID: 16985183
    [Abstract] [Full Text] [Related]

  • 2. Intravascular large B cell lymphoma in Taiwan: an Asian variant of non-germinal-center origin.
    Hsieh MS, Yeh YC, Chou YH, Lin CW.
    J Formos Med Assoc; 2010 Mar 15; 109(3):185-91. PubMed ID: 20434026
    [Abstract] [Full Text] [Related]

  • 3. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.
    Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, Suzumiya J, Murase T, Miura I, Akasaka T, Tamaru J, Suzuki R, Kagami Y, Hirano M, Morishima Y, Ueda R, Shiku H, Nakamura S.
    Blood; 2002 Feb 01; 99(3):815-21. PubMed ID: 11806981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H, Shimada K, Shimada S, Abe M, Okamoto M, Kitamura K, Kinoshita T, Shiraishi T, Nakamura S.
    Pathol Int; 2009 Jul 01; 59(7):431-7. PubMed ID: 19563405
    [Abstract] [Full Text] [Related]

  • 7. [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].
    Kado H, Hatta T, Ueno R, Takagi A, Segawa H, Sawada K, Hosokawa Y.
    Nihon Jinzo Gakkai Shi; 2011 Jul 01; 53(7):1046-52. PubMed ID: 22073871
    [Abstract] [Full Text] [Related]

  • 8. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.
    Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, Suzuki H, Oyama A, Kodera Y, Ueda R, Morishima Y, Nakamura S, Seto M.
    Leukemia; 1999 Sep 01; 13(9):1441-7. PubMed ID: 10482997
    [Abstract] [Full Text] [Related]

  • 9. High Frequency of Bone Marrow Involvement in Intravascular Large B-Cell Lymphoma.
    Wang J, Ding W, Gao L, Yao W, Chen M, Zhao S, Liu W, Zhang W.
    Int J Surg Pathol; 2017 Apr 01; 25(2):118-126. PubMed ID: 27553679
    [Abstract] [Full Text] [Related]

  • 10. Intravascular large B-cell lymphoma. A report of five cases initially diagnosed by bone marrow biopsy.
    Estalilla OC, Koo CH, Brynes RK, Medeiros LJ.
    Am J Clin Pathol; 1999 Aug 01; 112(2):248-55. PubMed ID: 10439806
    [Abstract] [Full Text] [Related]

  • 11. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A, Chadburn A, Knowles DM.
    Am J Pathol; 1995 Jul 01; 147(1):207-16. PubMed ID: 7541611
    [Abstract] [Full Text] [Related]

  • 12. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
    Yegappan S, Coupland R, Arber DA, Wang N, Miocinovic R, Tubbs RR, Hsi ED.
    Mod Pathol; 2001 Nov 01; 14(11):1147-56. PubMed ID: 11706077
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
    Kamihira S, Hirakata Y, Atogami S, Sohda H, Tsuruda K, Yamada Y, Tomonaga M.
    Leuk Lymphoma; 1996 Jun 01; 22(1-2):137-42. PubMed ID: 8724541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.
    Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C, Zucca E, Cavalli F, Nakamura S.
    J Clin Oncol; 2007 Jul 20; 25(21):3168-73. PubMed ID: 17577023
    [Abstract] [Full Text] [Related]

  • 17. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis.
    Segal GH, Masih AS, Fox AC, Jorgensen T, Scott M, Braylan RC.
    Blood; 1995 Mar 15; 85(6):1570-9. PubMed ID: 7534138
    [Abstract] [Full Text] [Related]

  • 18. Intravascular large B-cell lymphoma with cutaneous manifestations: a clinicopathologic, immunophenotypic and molecular study of three cases.
    Kong YY, Dai B, Sheng WQ, Yang WT, Wang CF, Kong JC, Shi DR.
    J Cutan Pathol; 2009 Aug 15; 36(8):865-70. PubMed ID: 19040469
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.